Hinge Health, Inc.
HNGE
$54.06
-$1.16-2.10%
NYSE
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 47.23% | 45.60% | 53.27% | 54.85% | 49.71% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 47.23% | 45.60% | 53.27% | 54.85% | 49.71% |
| Cost of Revenue | 18.55% | 25.43% | 30.84% | 74.26% | -4.75% |
| Gross Profit | 53.98% | 50.04% | 59.32% | 48.09% | 72.99% |
| SG&A Expenses | 43.29% | 59.10% | 69.21% | 572.55% | 6.70% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 35.73% | 48.91% | 53.43% | 570.32% | -3.02% |
| Operating Income | 144.11% | 30.35% | -57.65% | -3,208.47% | 141.81% |
| Income Before Tax | 98.17% | 23.13% | -212.97% | -5,313.08% | 168.95% |
| Income Tax Expenses | -18.44% | 112.83% | -81.42% | -190.86% | 531.65% |
| Earnings from Continuing Operations | 104.96% | 18.36% | -640.76% | -5,159.36% | 164.76% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 104.96% | 18.36% | -640.76% | -5,159.36% | 164.76% |
| EBIT | 144.11% | 30.35% | -57.65% | -3,208.47% | 141.81% |
| EBITDA | 138.58% | 29.35% | -70.18% | -3,313.11% | 144.27% |
| EPS Basic | -94.53% | -79.61% | -541.51% | -1,271.38% | 500.14% |
| Normalized Basic EPS | -61.36% | -78.79% | -119.82% | -1,311.61% | 160.18% |
| EPS Diluted | -68.44% | -80.82% | -541.51% | -1,272.04% | 166.16% |
| Normalized Diluted EPS | 123.08% | -80.05% | -124.12% | -1,311.61% | 109.95% |
| Average Basic Shares Outstanding | 412.78% | 480.61% | 478.86% | 224.74% | 14.56% |
| Average Diluted Shares Outstanding | -11.16% | 517.21% | 375.51% | 224.74% | 593.01% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |